Connor, Clark & Lunn Investment Management Ltd.
Position in EBS — Emergent BioSolutions Inc.
CIK 1596800
VANCOUVER, A1
Position in EBS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,966,377
-$2,415,152 QoQ
Shares Held
353,983
-45.4% QoQ
Ownership
0.690%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#31
of 193 holders
Holding Since
Jun 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $83,482,045 across 14 Drug Manufacturers - Specialty & Generic names. EBS ranks #7 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
572,598 | $36,617,642 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
721,002 | $12,949,195 | |
| 3 | ZTS |
Zoetis Inc.
|
118,491 | $8,514,763 | |
| 4 | IRWD |
Ironwood Pharmaceuticals Inc
|
1,811,714 | $7,627,315 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
192,766 | $6,530,911 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
231,979 | $3,361,375 | |
| 7 | EBS |
Emergent BioSolutions Inc.
This page
|
353,983 | $2,966,377 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
95,381 | $2,347,326 |
All Filings in EBS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,966,377 | 353,983 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,381,529 | 648,377 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $9,616,067 | 777,999 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $9,986,930 | 1,132,305 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,294,973 | 986,673 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $4,527,707 | 931,627 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $8,626,293 | 902,332 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $6,957,011 | 833,175 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $5,751,906 | 843,388 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,786,774 | 706,235 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $505,089 | 210,454 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $712,415 | 209,534 | Shares | Sole | 2023-11-13 | |
| 2023-03-31 | $475,057 | 45,855 | Shares | Sole | 2023-05-10 | |
| 2020-09-30 | $4,066,035 | 39,350 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,773,052 | 22,421 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||